Vaxzevria

(Note 2)

COVID-19 (SARS-CoV-2) Vaccine (recombinant chimpanzee adenovirus vector)

Approval Information

Brand NameVaxzevria

Generic NameCOVID-19 (SARS-CoV-2) Vaccine (recombinant chimpanzee adenovirus vector)

ApprovedMay 2021

Type(Note 2)

Review Reports

English Review Report

PDF · 1.97 MB

Japanese Review Report (1)

PDF · 1.84 MB

Japanese Review Report (2)

PDF · 117.51 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database